CompoAtlas

PHYTOXIL IMMUNITE

Food supplement declared in France, declaration No 2020-8-182

PHYTOXIL IMMUNITE (PHYTOXIL) is a food supplement declared in France. Status: withdrawn from the market on 1 February 2023. None of the rules we check flags an issue with its declared composition.

Brand
PHYTOXIL
Food business operator placing the product on the market
SANOFI AVENTIS FRANCE
Status
Withdrawn from the market on 1 February 2023
Form
Capsule
Daily dose
4 gélules
Directions for use
4 gélules en 1 à 2 prise par jour à prendre avec un verre d'eau
Not recommended (according to the manufacturer)
Adolescents (under 18), Children (under 12)
Objectives stated by the manufacturer (these are not authorised claims)
Immunity

Declaration 308384, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Echinacea pallida (Nutt.) Nutt.Organes souterrainsPoudre (de plantes séchées ou broyées)405 mg
Uncaria tomentosa (Willd. ex Schult.) DC.EcorcePoudre (de plantes séchées ou broyées)401.8 mg
Echinacea pallida (Nutt.) Nutt.Organes souterrainsExtrait sec hydroalcoolique324 mg
Sambucus nigra L.BaieAutre extrait sec243 mg
Uncaria tomentosa (Willd. ex Schult.) DC.EcorceExtrait sec hydroalcoolique3.24 mg

Additives

E464, E414

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Réservé à l'adulte. Ne pas prendre si vous êtes allergiques à l'un des actifs ou additifs. Les personnes sous contrôle médical, les femmes enceintes ou allaitantes doivent demander conseil à leur médecin avant de prendre un complément alimentaire.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Echinacea pallida (Nutt.) Nutt.
    Read the warning, when it applies and the studies cited

    ECHINACEA - ECHINACEA PALLIDA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a progressive systemic disease such as tuberculosis, collagenosis, multiple sclerosis, or an immune system disorder (EMA 2018; Gardner and McGuffin 2013; Brinker 2010).

    Sources cited by Health Canada (3)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2018: EMA/HMPC/332350/2018 Community herbal monograph on ECHINACEA PALLIDA (NUTT.) NUTT., RADIX. London (GB): European Medicines Agency: Committee on Herbal Medicinal Products (HMPC). [Accessed 2025 November 24]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-echinacea-pallida-nutt-nutt-radix-revision-1_en.pdf
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications to suppress the immune system (Brinker 2010; Mills et al. 2006).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills E, Dugoua J, Perri D, Koren G. Herbal Medicines in Pregnancy and Lactation: An Evidence-Based Approach. London (GB): Taylor and Francis Medical; 2006.

    Health Canada monograph dated 19 December 2025

  • Sambucus nigra L.
    Read the warning, when it applies and the studies cited

    ELDER – SAMBUCUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Diaphoretic; Symptoms of colds, flus; Sinusitis, hay-fever; Joint pain.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occur (Forster-Waldl et al. 2003).

    Sources cited by Health Canada (1)
    • Förster-Waldl E, Marchetii M, Schöll I, Focke M, Radauer C, Kinaciyan T, Nentwich I, Jäger S, Schmid ER, Boltz-Nitulescu G, Scheiner O, Jensen-Jarolim E. Type I allergy to elderberry (Sambucus nigra) is elicited by a 33.2 kDa allergen with significant homology to ribosomal inactivating proteins. Clinical and Experimental Allergy 2003;33(2):1703-1710. PubMed

    Condition of application: All products except those making a diuretic claim.

    When using this product diuretic effect may occur (Bradley 1992; Winston and Kuhn 2008; Barnes et al. 2007; Hoffman 2003).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines. 3rd edition. London (GB): The Pharmaceutical Press; 2007.
    • Winston D and Kuhn MA. Herbal Therapy & Supplements A Scientific and Traditional Approach. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : PHYTOXIL

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.